Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience.

[1]  C. Reddy,et al.  Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer. , 2006, Urology.

[2]  Clifton D Fuller,et al.  Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[3]  Patrick A Kupelian,et al.  Influence of intrafraction motion on margins for prostate radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[4]  John T. Wei,et al.  Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. , 2006, International journal of radiation oncology, biology, physics.

[5]  David E. Stein,et al.  Management of radiotherapy induced rectourethral fistula. , 2006, The Journal of urology.

[6]  C. Ma,et al.  Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. , 2006, International journal of radiation oncology, biology, physics.

[7]  Patrick A Kupelian,et al.  Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. , 2005, International journal of radiation oncology, biology, physics.

[8]  M. Garzotto,et al.  Daily Verification of Prostate Motion Both with and Without a Rectal Balloon (RB) Over the Course of Treatment , 2005 .

[9]  W. Tomé,et al.  A Multi-Institutional Phase I/II Trial of Dose-per-fraction Escalation for Localized Prostate Cancer , 2005 .

[10]  K. Lam,et al.  Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols. , 2005, International journal of radiation oncology, biology, physics.

[11]  W. Cavanagh,et al.  Rectal fistulas after prostate brachytherapy. , 2005, International journal of radiation oncology, biology, physics.

[12]  Patrick A Kupelian,et al.  Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. , 2005, International journal of radiation oncology, biology, physics.

[13]  Jeff M Michalski,et al.  Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. , 2005, International journal of radiation oncology, biology, physics.

[14]  Eric Strom,et al.  Ultrasound-based localization. , 2005, Seminars in radiation oncology.

[15]  L. Schour,et al.  High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. , 2005, International journal of radiation oncology, biology, physics.

[16]  P. Koper,et al.  Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. , 2005, International journal of radiation oncology, biology, physics.

[17]  Judy Adams,et al.  A randomized trial comparing conventional dose (70.2GyE) and high-dose (79.2GyE) conformal radiation in early stage adenocarcinoma of the prostate: Results of an interim analysis of PROG 95–09 , 2004 .

[18]  Richard K Valicenti,et al.  Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. , 2004, International journal of radiation oncology, biology, physics.

[19]  J. Blasko,et al.  Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience. , 2003, International journal of radiation oncology, biology, physics.

[20]  Frank Van den Heuvel,et al.  Independent verification of ultrasound based image-guided radiation treatment, using electronic portal imaging and implanted gold markers. , 2003, Medical physics.

[21]  J. Pouliot,et al.  Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. , 2003, International journal of radiation oncology, biology, physics.

[22]  D. Kuban,et al.  Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all? , 2003, International journal of radiation oncology, biology, physics.

[23]  F. Vicini,et al.  The role of high-dose rate brachytherapy in locally advanced prostate cancer. , 2003, Seminars in radiation oncology.

[24]  L. Potters,et al.  Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[25]  David J Brenner,et al.  What hypofractionated protocols should be tested for prostate cancer? , 2002, International journal of radiation oncology, biology, physics.

[26]  V. Khoo,et al.  Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis. , 2002, International journal of radiation oncology, biology, physics.

[27]  R. Bristow,et al.  Hypofractionated intensity modulated radiation therapy for prostate cancer , 2002 .

[28]  J. Tsai,et al.  Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[29]  Michael J. Zelefsky,et al.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.

[30]  Patrick A Kupelian,et al.  Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[31]  E. B. Butler,et al.  Prostate immobilization using a rectal balloon , 2002, Journal of applied clinical medical physics.

[32]  J. Manola,et al.  A practical method to achieve prostate gland immobilization and target verification for daily treatment. , 2001, International journal of radiation oncology, biology, physics.

[33]  C. Reddy,et al.  Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. , 2001, International journal of radiation oncology, biology, physics.

[34]  C. Reddy,et al.  Dose/Volume Relationship of Late Rectal Bleeding After External Beam Radiotherapy for Localized Prostate Cancer: Absolute or Relative Rectal Volume? , 2001, Cancer journal.

[35]  J. Rieke,et al.  Development of apparatus and phase I trial for stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP) , 2001 .

[36]  Blasko,et al.  10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. , 2001, International journal of radiation oncology, biology, physics.

[37]  Rick Chappell,et al.  Is α/β for prostate tumors really low? , 2001 .

[38]  D Yan,et al.  An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[39]  G. Gustafson,et al.  Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial. , 2000, International journal of radiation oncology, biology, physics.

[40]  T R Willoughby,et al.  Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. , 2000, International journal of radiation oncology, biology, physics.

[41]  Duchesne Gm,et al.  What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. , 1999 .

[42]  T E Schultheiss,et al.  A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[43]  James D. Cox,et al.  Consensus statement: Guidelines for PSA following radiation therapy , 1997 .

[44]  E. Klein,et al.  Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone. , 1997, International Journal of Radiation Oncology, Biology, Physics.

[45]  B. Leibovich,et al.  Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. , 2005, The Journal of urology.

[46]  J Alfred Witjes,et al.  The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study. , 2005, International journal of radiation oncology, biology, physics.

[47]  D. Brenner,et al.  Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue , 2002 .

[48]  R. Pötter,et al.  The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[49]  A. Renshaw,et al.  Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.